Monica Arnedos Selected Research

Monica Arnedos Research Topics

Disease

26	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2007
20	Neoplasms (Cancer) 01/2022 - 12/2007
2	Triple Negative Breast Neoplasms 01/2021 - 07/2012
2	Lobular Carcinoma 07/2014 - 02/2011
1	Mucositis 10/2021
1	Exanthema (Rash) 10/2021
1	COVID-19 01/2021
1	Disease Progression 01/2020
1	Aneuploidy (Aneuploid) 11/2019
1	Rare Diseases (Rare Disease) 01/2014
1	Neoplasm Metastasis (Metastasis) 02/2011
1	Carcinoma (Carcinomatosis) 02/2011
1	Pain (Aches) 11/2008
1	Sepsis (Septicemia) 11/2008
1	Neutropenia 11/2008
1	Infertility (Sterility) 08/2008

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 10/2021 - 02/2011
5	Hormones (Hormone)IBA 01/2022 - 11/2007
4	Trastuzumab (Herceptin)FDA Link 10/2021 - 02/2014
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 03/2012
4	Estrogen ReceptorsIBA 01/2020 - 07/2012
3	Pharmaceutical PreparationsIBA 01/2020 - 02/2013
3	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 06/2012
3	Letrozole (Femara)FDA LinkGeneric 11/2014 - 11/2007
2	GenieIBA 01/2022 - 01/2020
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021 - 07/2012
2	Everolimus FDA Link 10/2021 - 10/2017
2	Biological ProductsIBA 10/2021 - 03/2013
2	TOR Serine-Threonine KinasesIBA 10/2021 - 10/2017
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 11/2013
2	Fulvestrant (Faslodex)FDA Link 01/2020 - 10/2019
2	Phosphotransferases (Kinase)IBA 01/2020 - 03/2012
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2019 - 11/2008
2	Phenobarbital (Luminal)FDA Link 10/2019 - 05/2015
2	Epidermal Growth Factor (EGF)IBA 05/2016 - 02/2014
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 03/2013 - 07/2012
2	Aromatase InhibitorsIBA 06/2012 - 11/2007
1	rucaparibIBA 12/2021
1	AntibodiesIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	durvalumabIBA 01/2021
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2021
1	KetonesIBA 01/2021
1	neratinibIBA 01/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 11/2019
1	Taxoids (Taxanes)IBA 11/2019
1	CyclinsIBA 10/2019
1	palbociclibIBA 10/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2017
1	MTOR InhibitorsIBA 02/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	LigandsIBA 03/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2012
1	human ERBB2 proteinIBA 07/2012
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2012
1	Aromatase (CYP19)IBA 06/2012
1	ParaffinIBA 06/2012
1	Formaldehyde (Formol)FDA Link 06/2012
1	Cyclin-Dependent Kinase 2IBA 03/2012
1	Monoclonal AntibodiesIBA 02/2011
1	Cadherins (E-Cadherin)IBA 02/2011
1	CateninsIBA 02/2011
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2008
1	Goserelin (Zoladex)FDA Link 08/2008
1	Tamoxifen FDA LinkGeneric 12/2007
1	exemestane (Aromasin)FDA Link 11/2007
1	Anastrozole (Arimidex)FDA LinkGeneric 11/2007

Therapy/Procedure

11	Therapeutics 01/2021 - 04/2007
5	Neoadjuvant Therapy 11/2019 - 11/2008
4	Adjuvant Chemotherapy 05/2015 - 08/2008
3	Drug Therapy (Chemotherapy) 01/2021 - 07/2012
2	Precision Medicine 12/2015 - 01/2014
1	Maintenance Chemotherapy 01/2021
1	Ketogenic Diet 01/2021
1	Time-to-Treatment 11/2019
1	Mastectomy (Mammectomy) 07/2014
1	Conservative Treatment 07/2014
1	Aftercare (After-Treatment) 08/2013
1	Treatment Delay 11/2008
1	Drug Tapering 11/2008